Keir Starmer suffers hit to economic plans after pharmaceutical giant ends £200m investment in Cambridge research site
Britain's largest drug-maker AstraZeneca has halted the £200million investment into its Cambridge research site in a hit to Sir Keir Starmer's economic plans. The decision means none of the pharmaceutical…
